 |
 |
| Biolase' stock price seemed unaffected when the company first filed its $30 million S-3 registration statement with the SEC on July 26, but following the latest quarterly results it lost two-thirds of its value within a couple of days. Source: Yahoo! Finance. |
| © 2024 SPIE Europe |
|
